The Green Organic Dutchman Announces 2020 AGSM Voting Results

PR Newswire

TORONTO, Dec. 15, 2020 /PRNewswire/ – The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX: TGOD) (US: TGODF) is pleased to announce the voting results from its Annual General and Special Meeting (the “Meeting“) of shareholders of the Company (“Shareholders“) held today in a virtual-only format.

All the matters put forward before Shareholders for consideration and approval as set out in the Company’s management information circular dated October 30th, 2020 (the “Circular“) were approved by the requisite majority of votes cast at the Meeting. In particular, Shareholders approved the election of all director nominees as follows:

Votes in Favour

Votes Withheld

% of Votes Cast in Favour (rounded)

Jeffrey J. Scott

62,587,391

8,438,901

88.12%

Marc Bertrand

62,816,568

8,214,724

88.44%

Nicholas G. Kirton

62,620,388

8,405,904

88.17%

Dr. Caroline MacCallum

62,964,738

8,061,554

88.65%

Jacques Dessureault

67,859,032

3,172,260

95.53%

Shareholders also approved the following items of business before the Meeting: the appointment of KPMG LLP as auditor of the Company for the ensuing year and the authorization of directors to fix their remuneration, the amended and restated Employee Stock Purchase Plan, the amended and restated Restricted Share Unit Plan, and the amended and restated By-law No.1.

The total number of common shares of the Company (“Common Shares“) represented by Shareholders and by proxy at the Meeting was 152,035,835 Common Shares, representing 34.70% of the Company’s total issued and outstanding Common Shares. Detailed voting results are available under the Company’s profile on SEDAR at www.sedar.com. A recording of the Meeting is available on the Company’s website at: https://tgod.ca/2020proxymaterials.

About The Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (US-OTC: TGODF) is a premium certified organically grown cannabis company focused on the health and wellness market. Its organic cannabis is cultivated in living soil, as nature intended. The Company is committed to cultivating a better tomorrow by producing its products responsibly, with less waste and impact on the environment. Its two Canadian facilities have been built to LEED certification standards and its products are sold in recyclable packaging. In Canada, TGOD sells dried flower and oil, and recently launched a series of next–generation cannabis products such as organic teas, dissolvables and vapes. Through its European subsidiary, HemPoland, the Company also distributes premium hemp CBD oil and CBD-infused topicals in Europe. By leveraging science and technology, TGOD harnesses the power of nature from seed to sale.

TGOD’s Common Shares and warrants issued under the indentures dated November 1, 2017, December 19, 2019, June 12, 2020 and October 23, 2020 and December 10, 2020 trade on the TSX under the symbol “TGOD”, “TGOD.WT”, “TGOD.WS”, “TGOD.WR”, “TGOD.WA” and “TGOD.WB”, respectively, and TGODF trades in the US on the OTCQX. For more information on The Green Organic Dutchman Holdings Ltd., please visit www.tgod.ca.

Forward-Looking Information Cautionary Statement

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accept responsibility for the adequacy or accuracy of this release.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/the-green-organic-dutchman-announces-2020-agsm-voting-results-301193576.html

SOURCE The Green Organic Dutchman Holdings Ltd.

SHAREHOLDER ALERT: WeissLaw LLP Investigates Big Rock Partners Acquisition Corp.

PR Newswire

NEW YORK, Dec. 15, 2020 /PRNewswire/ — WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Big Rock Partners Acquisition Corp. (“Big Rock” or the “Company”) (NASDAQ: BRPA) in connection with the Company’s proposed merger with privately-held clinical stage, small molecule pharmaceutical company NeuroRx, Inc. (“NeuroRx”).  Under the terms of the acquisition agreement, Big Rock will acquire NeuroRx through a reverse merger, with NeuroRx surviving as the new publicly-traded combined entity to trade on the NASDAQ Stock Market under the ticker symbol “NRXP.”  The combined company will have an estimated post-transaction equity value in excess of $500 million.


If you own Big Rock shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:


https://www.weisslawllp.com/BRPA/


Or please contact:



Joshua Rubin, Esq.

WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY  10036
(212) 682-3025
(888) 593-4771
[email protected]

WeissLaw is investigating whether Big Rock’s board acted in the best interest of Big Rock’s public shareholders in agreeing to the proposed transaction, whether the board was fully informed as to the valuation of NeuroRx, and whether all information regarding the process undertaken by the board and the valuation of the transaction will be fully and fairly disclosed to Big Rock public shareholders. 

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties.  We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases.  If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at [email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-investigates-big-rock-partners-acquisition-corp-301193560.html

SOURCE WeissLaw LLP

Semtech and AWS Collaborate on AWS IoT Core for LoRaWAN®

Semtech and AWS Collaborate on AWS IoT Core for LoRaWAN®

Fully managed feature for AWS IoT Core enables enterprises to seamlessly connect low power wireless devices to long range wide area network technology

CAMARILLO, Calif.–(BUSINESS WIRE)–Semtech Corporation (Nasdaq: SMTC), a leading supplier of high performance analog and mixed-signal semiconductors and advanced algorithms, announced that they have teamed up with Amazon Web Services (AWS) to integrate the LoRaWAN® protocol on the Network Server with AWS IoT Core, AWS’s managed Cloud service that lets connected devices easily and securely interact with Cloud applications and other devices.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201215006143/en/

Semtech and AWS Collaborate on AWS IoT Core for LoRaWAN (Graphic: Business Wire)

Semtech and AWS Collaborate on AWS IoT Core for LoRaWAN (Graphic: Business Wire)

AWS IoT Core for LoRaWAN is a fully managed service that enables enterprise IoT developers to easily connect low power wireless devices over long range, wide-area networks (LoRaWAN) to AWS without developing or operating their own LoRaWAN server. This simplifies the development of IoT solutions that leverage the long range, low power and security of Semtech’s LoRa chipsets and the LoRaWAN protocol.

To get started with AWS IoT Core for LoRaWAN, IoT developers can source AWS qualified gateways operating the LoRaWAN protocol from the AWS Partner Device Catalog and select an array of LoRaWAN CertifiedCM devices from the LoRa Alliance website. From within the AWS Management Console, developers can rapidly register gateways with AWS IoT Core for LoRaWAN by providing the service, its unique identifier, and selecting LoRaWAN as the radio frequency. To register devices with LoRa chipsets, developers simply input the device credentials, identifiers and security keys provided by the device vendor on the console and follow guided and easy instructions for specifying device configuration. In addition, AWS IoT Core for LoRaWAN includes a variety of device management capabilities, including security and a plug-and-play for the AWS IoT Analytics.

“Based on our collaboration with Semtech, IoT developers will be able to leverage LoRaWAN to simplify the development process, as well as provide key features to their applications such as long range connectivity, the ability to build devices with low power consumption, and increased security,” said Dirk Didascalou, Vice President of IoT, Amazon Web Services, Inc. “We are delighted to be working with Semtech to accelerate our customers’ adoption of IoT and LoRaWAN allowing them to innovate faster and focus on the main job of creating business value.”

Developers will also be able to access Semtech’s LoRa Cloud, a simple API-based service that can be easily integrated with AWS IoT Core for LoRaWAN, providing developers with the ability to locate any LoRaWAN enabled device including devices using Semtech’s recently released low power geolocation platform LoRa Edge.

“AWS IoT Core for LoRaWAN will speed IoT application development by providing a plug-and-play experience for developers,” said Mohan Maheswaran, Semtech’s President and CEO. “In addition, this collaboration with AWS enables enterprise customers using AWS to readily take advantage of the key benefits of LoRaWAN as the protocol continues to have massive adoption in the IoT industry in a variety of verticals ranging from smart home and communities to asset tracking.”

More was discussed at today’s AWS session at re:Invent. To learn more about Semtech’s IoT solutions, visit the website.

About Semtech’s LoRa® Platform

Semtech’s LoRa device-to-Cloud platform is a globally adopted long range, low power solution for IoT applications, enabling the rapid development and deployment of ultra-low power, cost efficient and long range IoT networks, gateways, sensors, module products, and IoT services worldwide. Semtech’s LoRa devices provide the communication layer for the LoRaWAN® protocol, which is maintained by the LoRa Alliance®, an open IoT alliance for Low Power Wide Area Network (LPWAN) applications that has been used to deploy IoT networks in over 100 countries. Semtech is a founding member of the LoRa Alliance. To learn more about how LoRa enables IoT, visit Semtech’s LoRa site.

About Semtech

Semtech Corporation is a leading supplier of high performance analog and mixed-signal semiconductors and advanced algorithms for infrastructure, high-end consumer and industrial equipment. Products are designed to benefit the engineering community as well as the global community. The Company is dedicated to reducing the impact it, and its products, have on the environment. Internal green programs seek to reduce waste through material and manufacturing control, use of green technology and designing for resource reduction. Publicly traded since 1967, Semtech is listed on the Nasdaq Global Select Market under the symbol SMTC. For more information, visit www.semtech.com.

Forward-Looking and Cautionary Statements

All statements contained herein that are not statements of historical fact, including statements that use the words “designed to” or other similar words or expressions, that describe Semtech Corporation’s or its management’s future plans, objectives or goals are “forward-looking statements” and are made pursuant to the Safe-Harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause the actual results of Semtech Corporation to be materially different from the historical results and/or from any future results or outcomes expressed or implied by such forward-looking statements. Such factors are further addressed in Semtech Corporation’s annual and quarterly reports, and in other documents or reports, filed with the Securities and Exchange Commission (www.sec.gov) including, without limitation, information under the captions “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Risk Factors.” Semtech Corporation assumes no obligation to update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release, except as required by law.

Semtech, the Semtech logo and LoRa are registered trademarks or service marks of Semtech Corporation or its affiliates.

SMTC-P

Ronda Grech

Semtech Corporation

(805) 250-1263

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Software Networks Internet Hardware Technology Semiconductor Mobile/Wireless Security

MEDIA:

Logo
Logo
Photo
Photo
Semtech and AWS Collaborate on AWS IoT Core for LoRaWAN (Graphic: Business Wire)

Delta 9 partner Oceanic Releaf Opens Cannabis Store in Burin Bay Arm, Newfoundland

BURIN, Newfoundland and Labrador, Dec. 15, 2020 (GLOBE NEWSWIRE) — DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) (“Delta 9” or the “Company”) and strategic partner Oceanic Releaf Inc. (“Oceanic”) are pleased to announce the grand opening of Oceanic’s first Cannabis Store in the Province of Newfoundland and Labrador. The retail store is located in Burin Bay Arm and opened on December 15, 2020. Delta 9 owns a 5% equity stake in Oceanic.

“With this newest store opening, we’re extremely excited to be able to offer the residents of the Burin Peninsula the best selection of Delta 9 cannabis products and to work with Oceanic to create a world class retail experience,” said John Arbuthnot, CEO of Delta 9. “We look forward to continuing to work with Oceanic on expanding their cultivation and retail operations in Newfoundland.”

The new store will be the largest cannabis retail store in the area offering a drive-through option for customers that want to remain in their cars when they make a purchase. This will be the first drive-through Cannabis store in the area.

“This is a major milestone for Oceanic and an exciting day for the residents of The Burin Peninsula. Not only are we opening a socially responsible and beautiful store, we are also making waves with the first Drive thru cannabis retail store,” said Taylor Giovannini, founder and President of Oceanic. “We are so excited to continue normalizing the cannabis industry and creating a genuine experience for all consumers. Offering coffee and multiple ways to purchase will elevate Oceanic’s reach and brand. The Drive thru is also key in this ongoing pandemic we are all facing and we are happy to adapt with the changing times.”

At approximately 2,300 square feet, the Oceanic Cannabis Retail Store is proud to serve the people of the Burin Peninsula. Located in the Heart of the Burin Peninsula on the main Street in Burin Arm Bay, close to the College of the North Atlantic Burin Campus and Regional Hospital. Main street is part of highway 220 that is the main throughfare loop for the Placentia Bay side of Burin Peninsula that connects to the Trans Canada.

The store is offering customers an open and modern shopping décor, highly trained staff and a wide range of products, including dried cannabis flower, cannabis oil, edibles, drinkables, concentrates, coffee, tea and a full assortment of cannabis accessories. Members of the public can also sign up for free cannabis education courses offered in the store’s education center.

For more information contact:
Investor & Media Contact:
Ian Chadsey VP Corporate Affairs
Mobile: 204-898-7722
E-mail: [email protected]

About Delta 9 Cannabis Inc.

Delta 9 Cannabis Inc. is a vertically integrated cannabis company focused on bringing the highest quality cannabis products to market. The company sells cannabis products through its wholesale and retail sales channels and sells its cannabis grow pods to other businesses. Delta 9’s wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. Delta 9’s shares trade on the Toronto Stock Exchange under the symbol “DN” and on the OTCQX under the symbol “VRNDF”. For more information, please visit www.delta9.ca.

About Oceanic

Oceanic is a vertically integrated cannabis company operating out of a 65,000sq /ft cultivation facility. Oceanic is opening its first of two retail stores in dec 2020. Oceanic will offer fresh, clean products from one of the last unspoiled areas in the world. We will produce premium cannabis for both medicinal and recreational use. With a vast range of products that will suit each individual preference, our offerings are guaranteed to please. We believe that high-quality cannabis can change the world. Based in the rural Newfoundland setting of the Burin Peninsula, Oceanic’s cultivation facility is housed in a converted secondary processing plant nestled in the community of Burin. Oceanic seeks to bring positive change to our communities through employment and wellness initiatives. We believe Oceanic, its products and its retail experiences, will reflect the best of what our province has to offer: creativity, personality and bravery – an uncommon experience for the keen cannabis consumer.


Disclaimer for Forward-Looking Information

Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company’s future business plans and other matters. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Forward looking statements in this news release include statements relating to the Company’s expansion plans. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including all risk factors set forth in the annual information form of Delta 9 dated March 19, 2020 which has been filed on SEDAR. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors carefully in evaluating the forward-looking statements contained in this news release and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. These forward-looking statements are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.



Aurinia and Lonza Announce Exclusive Agreement for Dedicated Voclosporin Manufacturing Capacity

Aurinia and Lonza Announce Exclusive Agreement for Dedicated Voclosporin Manufacturing Capacity

– State-of-the-Art Monoplant Will Provide Cost and Production Efficiency and Secure Active Pharmaceutical Ingredient (API) Supply for Future Commercial Demand –

VICTORIA, British Columbia–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (“Aurinia”) and Lonza Ltd. (SIX: LONN) (“Lonza“) today announced they have expanded their exclusive manufacturing relationship. The parties entered into a collaborative agreement to build a dedicated manufacturing capacity within Lonza’s existing small molecule API facility in Visp, Switzerland. The dedicated facility (also referred to as “monoplant”) will be equipped with state-of-the-art manufacturing equipment to provide cost and production efficiency for the manufacture of voclosporin, while expanding existing capacity and providing supply security to meet future commercial demand.

The new agreement builds on the parties’ successful multi-year relationship. The agreement, which is conditional upon U.S. regulatory approval of voclosporin, does not impact the launch supply for voclosporin as this is secured by existing inventory. The monoplant is estimated to be operational in 2023.

“Lonza’s world-class expertise and partnership have helped Aurinia to cost-effectively optimize the unique and complex manufacturing process required for the synthesis of voclosporin,” said Peter Greenleaf, President and Chief Executive Officer of Aurinia Pharmaceuticals. “We are currently well-poised and ready with adequate product supply for launch and anticipated market demand. A dedicated production capability will help keep our manufacturing costs down and ensure long-term flexibility to meet future demand for years to come.”

“This collaboration is a great example of how we can support both early and commercial-stage biopharmaceutical companies through innovation in manufacturing technology and flexible business models,” said Gordon Bates, President Small Molecules Division, Lonza. “We are looking forward to further developing our relationship with Aurinia into a long and productive collaboration to supply this innovative medicine to patients across the globe.”

Following U.S. regulatory approval of voclosporin, Aurinia will commence several capital expenditure payments. Upon completion of the monoplant, Aurinia will have the right to maintain unobstructed use of the monoplant by paying a quarterly fixed facility fee.

The U.S. Food and Drug Administration (FDA) accepted the filing of Aurinia’s NDA for voclosporin in the treatment of lupus nephritis (LN), granted Priority Review, and assigned a Prescription Drug User Fee Act (PDUFA) target action date of January 22, 2021.

About Voclosporin

Voclosporin is a novel therapy in development for patients with LN, an inflammation of the kidney which is one of the most serious complications of the autoimmune disease systemic lupus erythematosus (SLE). If left untreated, LN can lead to irreversible kidney damage, kidney failure or even death. Through an extensive clinical program, voclosporin has demonstrated superiority to the standard-of-care for LN. Voclosporin is now under review by the FDA with Fast Track status and Priority Review as a potential therapy for LN in the United States.

About Aurinia

Aurinia Pharmaceuticals is a late-stage clinical biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. The Company is currently seeking FDA approval of voclosporin for the potential treatment of LN. The Company’s head office is in Victoria, British Columbia and its U.S. commercial hub is in Rockville, Maryland. The Company focuses its development efforts globally.

About Lonza

At Lonza, we combine technological innovation with world class manufacturing and process excellence. Together, these enable our customers to deliver their discoveries in the healthcare, preservation, and protection sectors.

We are a preferred global partner to the pharmaceutical, biotech and specialty ingredients markets. We work to prevent illness and promote a healthier world by enabling our customers to deliver innovative medicines that help treat or even cure a wide range of diseases. We also offer a broad range of microbial control solutions, which help to create and maintain a healthy environment.

Founded in 1897 in the Swiss Alps, Lonza today operates in 120 sites and offices in more than 35 countries. With approximately 15,500 full-time employees, we are built from high-performing teams and of individual employees who make a meaningful difference to our own business, as well as the communities in which we operate. The company generated sales of CHF 5.9 billion in 2019 with a CORE EBITDA of CHF 1.6 billion. Find out more at www.lonza.com and follow us on Twitter @LonzaGroup or Facebook @LonzaGroupAG.

Forward-Looking Statements

Certain statements made in this press release may constitute forward-looking information within the meaning of applicable Canadian securities law and forward-looking statements within the meaning of applicable United States securities law. These forward-looking statements or information include but are not limited to statements or information with respect to: equipment at the monoplant facility being state-of-the-art; Aurinia expecting future commercial demand for voclosporin; the monoplant being operational by 2023; Aurinia being poised for increased adoption of and increased need for voclosporin; the PDUFA target action date of January 22, 2021. It is possible that such results or conclusions may change based on further analyses of these data. Words such as “anticipate”, “will”, “believe”, “estimate”, “expect”, “intend”, “target”, “plan”, “goals”, “objectives”, “may” and other similar words and expressions, identify forward-looking statements. We have made numerous assumptions about the forward-looking statements and information contained herein, including among other things, assumptions about: monoplant buildout occurring on anticipated timelines; Aurinia will be able to obtain all necessary regulatory approvals for commercialization of voclosporin for use in LN on terms that are acceptable to it and that are commercially viable; and that Aurinia’s intellectual property rights are valid and do not infringe the intellectual property rights of other parties. Even though management of Aurinia believes that the assumptions made, and the expectations represented by such statements or information are reasonable, there can be no assurance that the forward-looking information will prove to be accurate.

Forward-looking information by their nature are based on assumptions and involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aurinia to be materially different from any future results, performance or achievements expressed or implied by such forward-looking information. Should one or more of these risks and uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in forward-looking statements or information. Such risks, uncertainties and other factors include, among others, the following: difficulties we may experience in completing the development and commercialization of voclosporin; and the monoplant may have operational issues once underway that could result in production being limited or reduced from anticipated capacities; the monoplant could be subject to delays in construction, or construction may not be completed at all; the market for voclosporin for use in LN may not be as anticipated. Although we have attempted to identify factors that would cause actual actions, events or results to differ materially from those described in forward-looking statements and information, there may be other factors that cause actual results, performances, achievements or events to not be as anticipated, estimated or intended.

Also, many of the factors are beyond our control. There can be no assurance that forward-looking statements or information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, you should not place undue reliance on forward-looking statements or information.

Except as required by law, Aurinia will not update forward-looking information. All forward-looking information contained in this press release is qualified by this cautionary statement. Additional information related to Aurinia, including a detailed list of the risks and uncertainties affecting Aurinia and its business can be found in Aurinia’s most recent Annual Information Form available by accessing the Canadian Securities Administrators’ System for Electronic Document Analysis and Retrieval (SEDAR) website at www.sedar.com or the U.S. Securities and Exchange Commission’s Electronic Document Gathering and Retrieval System (EDGAR) website at www.sec.gov/edgar.

Additional Information and Disclaimer (Lonza)

Lonza Group Ltd has its headquarters in Basel, Switzerland, and is listed on the SIX Swiss Exchange. It has a secondary listing on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Lonza Group Ltd is not subject to the SGX-ST’s continuing listing requirements but remains subject to Rules 217 and 751 of the SGX-ST Listing Manual.

Certain matters discussed in this news release may constitute forward-looking statements. These statements are based on current expectations and estimates of Lonza Group Ltd, although Lonza Group Ltd can give no assurance that these expectations and estimates will be achieved. Investors are cautioned that all forward-looking statements involve risks and uncertainty and are qualified in their entirety. The actual results may differ materially in the future from the forward-looking statements included in this news release due to various factors. Furthermore, except as otherwise required by law, Lonza Group Ltd disclaims any intention or obligation to update the statements contained in this news release.

Investors & Corporate:

Glenn Schulman, PharmD, MPH

Corporate Communications, Aurinia

[email protected]

Media Contacts:

Dana Lynch

Corporate Communications, Aurinia

[email protected]

Stefan Riley

Ten Bridge Communications

[email protected]

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Health Manufacturing Clinical Trials Other Manufacturing Pharmaceutical Biotechnology

MEDIA:

Logo
Logo

Churchill Capital Corp V Announces Pricing of $450 Million Initial Public Offering

PR Newswire

NEW YORK, Dec. 15, 2020 /PRNewswire/ — Churchill Capital Corp V (the “Company”) announced the pricing of its initial public offering of 45,000,000 units at $10.00 per unit. The units will be listed on the New York Stock Exchange (the “NYSE”) under the symbol “CCV.U” commencing on December 16, 2020. Each unit consists of one share of the Company’s Class A common stock and one-fourth of one warrant, each whole warrant entitling the holder thereof to purchase one share of the Company’s Class A common stock at an exercise price of $11.50 per share. Once the securities constituting the units begin separate trading, we expect that the Class A common stock and warrants will be listed on the NYSE under the symbols “CCV” and “CCV WS,” respectively.

Churchill Capital Corp V was founded by Michael Klein, who is also the founder and managing partner of M. Klein and Company. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It may pursue an initial business combination target in any business or industry.

Citigroup Global Markets Inc. (“Citigroup”) is acting as joint bookrunner and representative of the underwriters and each of Goldman Sachs & Co. LLC (“Goldman Sachs”), J.P. Morgan Securities LLC (“J.P. Morgan”) and BofA Securities (“BofA”) is acting as joint bookrunner. B. Riley Securities, Inc. is acting as co-manager. The Company has granted the underwriters a 45-day option to purchase up to 6,750,000 additional units at the initial public offering price to cover over-allotments, if any.

This offering will only be made by means of a prospectus. Copies of the preliminary prospectus relating to the offering and final prospectus, when available, may be obtained from Citigroup, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717 or by telephone at (800) 831-9146; Goldman Sachs, Attention: Prospectus Department, 200 West Street, New York, NY 10282, telephone: +1 866 471 2526, facsimile: +1 212 902 9316, or email: [email protected]; J.P. Morgan, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, telephone: 866-803-9204, email: [email protected]; and BofA, 200 North College Street, 3rd Floor, Charlotte, NC 28255-0001, Attn: Prospectus Department, or email: [email protected].

A registration statement relating to these securities has been declared effective by the U.S. Securities and Exchange Commission (the “SEC”). This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any State or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such State or jurisdiction.

FORWARD-LOOKING STATEMENTS

This press release contains statements that constitute “forward-looking statements,” including with respect to the proposed initial public offering and the anticipated use of the net proceeds. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and preliminary prospectus for the Company’s offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Cision View original content:http://www.prnewswire.com/news-releases/churchill-capital-corp-v-announces-pricing-of-450-million-initial-public-offering-301193572.html

SOURCE Churchill Capital Corp V

Comcast to Provide Free WiFi at 10 Fresno Housing and Boys & Girls Clubs Locations in California’s Central Valley

Comcast to Provide Free WiFi at 10 Fresno Housing and Boys & Girls Clubs Locations in California’s Central Valley

Comcast Donates $50,000 to Each Organization and Donates 225 Laptops, 12 Months of Free Internet Service and 225 Food Boxes to Central Valley Families in Need

FRESNO, Calif.–(BUSINESS WIRE)–
As part of its ongoing commitment to help connect low-income individuals to the Internet so they can fully participate in educational opportunities and the digital economy, Comcast today announced initial plans to equip 10 Fresno Housing and Boys & Girls Clubs of Fresno County locations throughout the Central Valley with WiFi-connected “Lift Zones” over the coming months. Additional sites will be added over time. By providing robust WiFi coverage at safe spaces, Comcast intends to help thousands of low-income students get online, participate in distance learning and do their homework.

In addition to providing free WiFi service at the Lift Zone locations, Comcast donated $50,000 to the Boys & Girls Clubs of Fresno County to offer distance learning to more students and another $50,000 to Fresno Housing to help residents with digital literacy training and support. Comcast will also provide 225 Boys & Girls Clubs of Fresno County youth with a laptop computer, free Internet at home for 12 months (to eligible families) through its Internet Essentials program and a box with $100 worth of food.

“Lift Zones” feature free WiFi provided by Comcast, which allows students to work on laptops simultaneously so they can successfully participate in distance learning. This initiative provides free connectivity inside partner community centers for the next three years. By donating 225 laptops and 12 months of free Internet at home, Comcast and Telemundo are creating a seamless learning experience for children in the Central Valley.

“While some children can participate in distance learning at home, the children of essential workers and others may not have that privilege,” said John Gauder, Senior Vice President, Comcast California. “By providing free WiFi access at these Lift Zones, combined with a free laptop and free Internet access at home, we can ensure that the students can actively participate in classwork and complete assignments wherever they are. As a result, all these children can receive the best possible education and be set up for a more equitable, prosperous future.”

“The COVID-19 pandemic is having a disproportionate effect on our rural communities,” said Congressmember Jim Costa (CA-16). “The lack of internet access in these areas adds undue stress on families that are trying to balance telework and children’s distance learning. I’m pleased that Comcast has prioritized the Central Valley for this important initiative to help residents and children during this crisis.”

“The COVID-19 pandemic has shown the inequities not only in our health care system but in the digital divide that greatly impacts our most vulnerable communities,” said Assemblymember Dr. Joaquin Arambula (District 31). “Too many children in low-income neighborhoods and disadvantaged rural and unincorporated areas have been left behind in their education because they don’t have access to the internet, Wi-Fi, and/or devices. I’m grateful to Comcast for its generous commitment. It is a step in the right direction to keep these children and families connected and focused on a brighter future.”

“The COVID-19 crisis continues to put many low-income students at risk of being left behind. This Comcast commitment will accelerate a solution for comprehensive, digital equity and Internet adoption programs to support them,” said Diane Carbray, President/CEO of Boys & Girls Clubs of Fresno County. “We hope these Lift Zones from Comcast will help students who have been unable to fully participate in the current educational experience due to constraints of distance learning or a variety of other reasons that are outside of their control.”

“Fresno Housing’s mission is to create vibrant communities, build quality affordable housing, and support the success of approximately 50,000 residents throughout Fresno county,” said Preston Prince, CEO of Fresno Housing. “This partnership with Comcast is coming at a critical time, when there is so much need among our communities, and will help support our ongoing broadband improvement efforts. The global pandemic has disproportionately impacted communities of color and has put numerous children at risk of missing out on important educational opportunities. We are grateful to collaborate with Comcast to ease the struggle among our families and provide them with the support they need to be successful, especially in these challenging times.”

Lift Zone sites complement Comcast’s Internet Essentials program, which has helped connect more than 8 million low-income people to the Internet at home. This includes more than one million residents across California, which is the number one state in terms of overall participation in the Internet Essentials program.

About Comcast Corporation

Comcast Corporation (Nasdaq: CMCSA) is a global media and technology company with three primary businesses: Comcast Cable, NBCUniversal, and Sky. Comcast Cable is one of the United States’ largest video, high-speed Internet, and phone providers to residential customers under the Xfinity brand, and also provides these services to businesses. It also provides wireless and security and automation services to residential customers under the Xfinity brand. NBCUniversal is global and operates news, entertainment and sports cable networks, the NBC and Telemundo broadcast networks, television production operations, television station groups, Universal Pictures, and Universal Parks and Resorts. Sky is one of Europe’s leading media and entertainment companies, connecting customers to a broad range of video content through its pay television services. It also provides communications services, including residential high-speed Internet, phone, and wireless services. Sky operates the Sky News broadcast network and sports and entertainment networks, produces original content, and has exclusive content rights. Visit www.comcastcorporation.com for more information.

Joan Hammel

Comcast California

[email protected]

Mobile: (925) 519-4874

Kathryn Weakland

Boys & Girls Clubs of Fresno County

[email protected]

Mobile: (559) 977-0880

Fidel Contreras

Fresno Housing

[email protected]

Mobile: (559) 246-9827

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Other Philanthropy Women Consumer Electronics Technology Men Family Other Entertainment TV and Radio Mobile/Wireless Consumer Entertainment Children Other Technology Philanthropy Telecommunications Fund Raising Primary/Secondary Education Internet Hardware

MEDIA:

AdaptHealth Announces Pricing of $500 Million 4.625% Senior Notes Due 2029

AdaptHealth Announces Pricing of $500 Million 4.625% Senior Notes Due 2029

PLYMOUTH MEETING, Pa.–(BUSINESS WIRE)–AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a leading provider of home healthcare equipment, medical supplies to the home and related services in the United States, announced today that its subsidiary, AdaptHealth LLC (the “Issuer”), has priced an offering of $500 million aggregate principal amount of 4.625% senior notes due 2029 (the “senior notes”). The senior notes will be issued at a price of 100.00% of their principal amount.

The gross proceeds from the offering will be deposited into a segregated escrow account pending completion of the Company’s previously announced acquisition of AeroCare Holdings, Inc. (“AeroCare”). At the closing of the AeroCare acquisition, the net proceeds from the offering will be released from escrow and, together with term loan borrowings and cash on hand, will be used to finance the cash portion of the consideration for the AeroCare acquisition and to pay related fees and expenses. The gross proceeds from the offering will replace the outstanding bridge commitment the Issuer has in place with Jefferies Finance LLC in connection with funding the AeroCare acquisition.

The AeroCare acquisition is expected to close in the first quarter of 2021, subject to customary closing conditions. If the AeroCare acquisition is not completed by May 31, 2021 (or such earlier date on which the Issuer determines that the escrow release conditions cannot be satisfied), the Issuer will be required to redeem the senior notes at a redemption price equal to 100% of the principal amount of the senior notes, plus accrued and unpaid interest, if any, to, but excluding, the redemption date.

The senior notes will be guaranteed by certain of the Issuer’s current and future subsidiaries (including AeroCare and its subsidiaries after the consummation of the AeroCare acquisition), as well as the Issuer’s direct parent, AdaptHealth Intermediate Holdco LLC, on a senior unsecured basis. The offering is expected to be completed on January 4, 2021, subject to the satisfaction of customary closing conditions.

The senior notes and related guarantees are being offered only to investors who are reasonably believed to be “qualified institutional buyers” in reliance on the exemption from registration set forth in Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and outside the United States to non-U.S. persons in reliance on the exemption from registration set forth in Regulation S under the Securities Act. The senior notes and the related guarantees have not been registered under the Securities Act, or the securities laws of any state or other jurisdiction, and may not be offered or sold in the United States without registration or an applicable exemption from the Securities Act and applicable state securities or blue sky laws and foreign securities laws.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of senior notes in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

About AdaptHealth Corp.

AdaptHealth is a leading provider of home healthcare equipment, medical supplies to the home and related services in the United States. AdaptHealth provides a full suite of medical products and solutions designed to help patients manage chronic conditions in the home, adapt to life and thrive. Product and services offerings include (i) sleep therapy equipment, supplies and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea, (ii) medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors and insulin pumps), (iii) home medical equipment (HME) to patients discharged from acute care and other facilities, (iv) oxygen and related chronic therapy services in the home, and (v) other HME medical devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The Company is proud to partner with an extensive and highly diversified network of referral sources, including acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics. AdaptHealth services beneficiaries of Medicare, Medicaid and commercial insurance payors. AdaptHealth services approximately 1.8 million patients annually in all 50 states through its network of 269 locations in 41 states.

Forward-Looking Statements

This press release includes certain statements that are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook,” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding projections, estimates and forecasts of revenue and other financial and performance metrics and projections of market opportunity and expectations and the Company’s acquisition pipeline. These statements are based on various assumptions and on the current expectations of AdaptHealth management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on, by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of the Company.

These forward-looking statements are subject to a number of risks and uncertainties, including the outcome of judicial and administrative proceedings to which the Company may become a party or governmental investigations to which the Company may become subject that could interrupt or limit the Company’s operations, result in adverse judgments, settlements or fines and create negative publicity; changes in the Company’s clients’ preferences, prospects and the competitive conditions prevailing in the healthcare sector; and the impact of the coronavirus (COVID-19) pandemic and the Company’s response to it. A further description of such risks and uncertainties can be found in the Company’s filings with the Securities and Exchange Commission from time to time. If the risks materialize or assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that the Company presently knows or that the Company currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect the Company’s expectations, plans or forecasts of future events and views as of the date of this press release. The Company anticipates that subsequent events and developments will cause the Company’s assessments to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s assessments as of any date subsequent to the date of this press release. Accordingly, undue reliance should not be placed upon the forward-looking statements.

AdaptHealth Corp.

Jason Clemens, CFA

Chief Financial Officer

(484) 301-6599

[email protected]

Brittany Lett

Vice President, Marketing

(909) 915-4983

[email protected]

The Equity Group Inc.

Devin Sullivan

Senior Vice President

(212) 836-9608

[email protected]

Kalle Ahl, CFA

Vice President

(212) 836-9614

[email protected]

KEYWORDS: Pennsylvania United States North America

INDUSTRY KEYWORDS: General Health Health Medical Supplies Medical Devices

MEDIA:

Logo
Logo

SHAREHOLDER ALERT: WeissLaw LLP Investigates TPG Pace Beneficial Finance Corp.

PR Newswire

NEW YORK, Dec. 15, 2020 /PRNewswire/ — WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of TPG Pace Beneficial Finance Corp. (“TPG” or the “Company”) (NYSE: TPGY) in connection with the Company’s agreement to acquire EV Charged B.V. (“EVBox”), a privately-held provider of smart charging solutions for electric vehicles, for a combination of cash and equity.  Under the terms of the merger agreement, TPG will acquire EVBox through a reverse merger, with EVBox surviving as the new publicly-traded combined entity with its common stock to trade on the New York Stock Exchange under the ticker symbol “EVB.”  The proposed transaction values EVBox at an implied $969 million enterprise value and a total pro forma equity value of approximately $1.394 billion.


If you own TPG shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:


https://www.weisslawllp.com/TPGY/


Or please contact:



Joshua Rubin, Esq.

WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY  10036
(212) 682-3025
(888) 593-4771
[email protected]

WeissLaw is investigating whether TPG’s board acted in the best interest of TPG’s public shareholders in agreeing to the proposed transaction, whether the board was fully informed as to the valuation of EVBox, and whether all information regarding the process undertaken by the board and the valuation of the transaction will be fully and fairly disclosed to TPG public shareholders. 

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties.  We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases.  If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at [email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-investigates-tpg-pace-beneficial-finance-corp-301193559.html

SOURCE WeissLaw LLP

Gores Holdings VI, Inc. Completes $345 Million Initial Public Offering

Gores Holdings VI, Inc. Completes $345 Million Initial Public Offering

BOULDER, Colo.–(BUSINESS WIRE)–
Gores Holdings VI, Inc. (the “Company”), a blank check company sponsored by an affiliate of The Gores Group, LLC, a global investment firm founded in 1987 by Alec Gores, and formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, today announced the closing of its initial public offering of 34,500,000 units, which includes 4,500,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $345,000,000, before deducting underwriting discounts and commissions and other offering expenses payable by the Company.

The Company’s units began trading on the Nasdaq Capital Market under the ticker symbol “GHVIU” on December 11, 2020. Each unit consists of one share of the Company’s Class A common stock and one-fifth of one warrant. Each whole warrant entitles the holder thereof to purchase one share of the Company’s Class A common stock at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the Class A common stock and warrants are expected to be listed on the Nasdaq Capital Market under the ticker symbols “GHVI” and “GHVIW,” respectively.

Deutsche Bank Securities Inc. and Morgan Stanley & Co. LLC are serving as joint book-running managers for the offering. The offering was made only by means of a prospectus, copies of which may be obtained from Deutsche Bank Securities Inc., Attn: Prospectus Department, 60 Wall Street, New York, New York 10005, telephone: 800-503-4611 or email: [email protected] and Morgan Stanley & Co. LLC, Attn: Prospectus Department, 180 Varick, 2nd Floor, New York, New York 10014, telephone: 866-718-1649 or email: [email protected].

A registration statement relating to the securities became effective on December 10, 2020, in accordance with Section 8(a) of the Securities Act of 1933, as amended. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

This press release contains statements that constitute “forward-looking statements,” including with respect to the proposed initial public offering and the anticipated use of the net proceeds. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and preliminary prospectus for the Company’s offering filed with the Securities and Exchange Commission (“SEC”). Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Jennifer Kwon Chou

Managing Director, The Gores Group

(310) 209-3010

[email protected]

KEYWORDS: Colorado United States North America

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA: